Siltuximab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Siltuximab. Educational only — not medical advice.
Labeled uses
SYLVANT is indicated for the treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.
Source: FDA labeling via NIH DailyMed (set 8d663642…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.